ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,162, issued on Jan. 20, was assigned to Phoremost Ltd. (Pampisford, Great Britain).
"Method of screening for peptides capable of binding to a ubiquitin protein ligase (E3)" was invented by Markus Muellner (Pampisford, Great Britain), Alberto Moreno (Pampisford, Great Britain), Marta Carrara (Pampisford, Great Britain) and Jennifer Howes (Pampisford, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method of screening for peptides capable of binding to a ubiquitin protein ligase (E3), successful binding being determined by detecting the amount of a test protein in the cell. The invention relates to a met...